Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Witjes

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Reproductive Biology and Endocrinology : RB&E|June 14, 2013
Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trialArthur Leader, Paul Devroey, Han Witjes, et al.
Reproductive Biomedicine Online|February 6, 2010
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cyclesKevin Doody, Paul Devroey, Keith Gordon, et al.
Human Reproduction (Oxford, England)|November 9, 2012
High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocolHuman M Fatemi, Kevin Doody, Georg Griesinger, et al.
Reproductive Biomedicine Online|August 23, 2011
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfaKevin J Doody, Paul Devroey, Arthur Leader, et al.
Clinical Pharmacology and Therapeutics|September 11, 2019
Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab SuperiorityHan Witjes, Amit Khatri, Paul M Diderichsen, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 26, 2015
Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrheaHan Witjes, Mitchell D Creinin, Inger Sundström-Poromaa, et al.
Fertility and Sterility|March 31, 2012
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormoneRobert Boostanfar, Bernadette Mannaerts, Samuel Pang, et al.
Reproductive Biomedicine Online|August 17, 2011
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSHGeorge Griesinger, Daniel B Shapiro, Efstratios M Kolibianakis, et al.
Fertility and Sterility|October 3, 2013
Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trialsGeorg Griesinger, Bernadette Mannaerts, Claus Yding Andersen, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 24, 2003
Multispectral magnetic resonance image analysis using principal component and linear discriminant analysisHan Witjes, Mark Rijpkema, Marinette van der Graaf, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Reproductive Biology and Endocrinology : RB&E|June 14, 2013
Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trialArthur Leader, Paul Devroey, Han Witjes, et al.
Reproductive Biomedicine Online|February 6, 2010
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cyclesKevin Doody, Paul Devroey, Keith Gordon, et al.
Human Reproduction (Oxford, England)|November 9, 2012
High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocolHuman M Fatemi, Kevin Doody, Georg Griesinger, et al.
Reproductive Biomedicine Online|August 23, 2011
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfaKevin J Doody, Paul Devroey, Arthur Leader, et al.
Clinical Pharmacology and Therapeutics|September 11, 2019
Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab SuperiorityHan Witjes, Amit Khatri, Paul M Diderichsen, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 26, 2015
Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrheaHan Witjes, Mitchell D Creinin, Inger Sundström-Poromaa, et al.
Fertility and Sterility|March 31, 2012
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormoneRobert Boostanfar, Bernadette Mannaerts, Samuel Pang, et al.
Reproductive Biomedicine Online|August 17, 2011
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSHGeorge Griesinger, Daniel B Shapiro, Efstratios M Kolibianakis, et al.
Fertility and Sterility|October 3, 2013
Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trialsGeorg Griesinger, Bernadette Mannaerts, Claus Yding Andersen, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 24, 2003
Multispectral magnetic resonance image analysis using principal component and linear discriminant analysisHan Witjes, Mark Rijpkema, Marinette van der Graaf, et al.
Pageof 3